Stem cell bank completes $2M stock buyback

OLDSMAR -- Cryo-Cell International Inc. completed a nearly $2 million buyback of stock, putting 6% of the company back in corporate hands.

Founded as a private cord blood bank to separate and store stem cells, Cryo-Cell had offered to buy back as much as 750,000 shares of its common stock through midnight Tuesday. It's $3.25 per share price was slightly lower than the company's 52-week high of $3.50.

The buyback did help push up share prices a bit, which closed above the $3 mark July 1 for the first time since last December. Cryo-Cell, which trades over-the-counter under the symbol CCEL, closed Thursday at $3.04, flat with the price from the day before.